Expression and clinical significance of mismatch repair gene in colorectal cancer
10.3969/j.issn.1000-8179.2018.19.516
- VernacularTitle:错配修复基因蛋白在结直肠癌诊治中的临床应用
- Author:
Chunhua QIU
1
;
Zhihong ZHANG
;
Dandan DONG
;
Liangping LI
Author Information
1. 四川省医学科学院?四川省人民医院消化内科
- Keywords:
mismatch repair gene (MMR);
colorectal cancer;
Lynch syndrome;
clinicopathology
- From:
Chinese Journal of Clinical Oncology
2018;45(19):1005-1008
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the expression and clinical significance of mismatch repair genes (MMR) MLH1, MSH2, MSH6, and PMS2 in colorectal carcinoma. Methods: Colorectal cancer tissues, collected from 607 patients enrolled in Sichuan Provincial People's Hospital from January 2015 to September 2016, were assigned into two groups based on whether the samples were positive or nega-tive for MMR expression to determine the relationship between MMR expression and clinicopathology. We then evaluated the diag-nostic value of MMR expression in the screening of Lynch syndrome and sporadic colorectal cancer. Results: The deletion rate of MMR protein was 35.58%. No statistically significant difference in age, sex, tumor size, P53, CD34, and D2-40 expression was detected be-tween the negative group with MMR protein deficiency and the positive group with normal expression (P>0.05). Differences in tumor location, differentiation, TNM stage, lymph node metastasis, and VEGF and Ki-67 expression between the two groups were statistically significant (P<0.05). The combined detection of MLH1, MSH2, PSM2, and MSH6 proteins may serve as a simple and economical meth-od for screening patients with Lynch syndrome. Conclusions: The risk of colorectal cancer can be reduced by MMR detection of surgi-cal specimens from colorectal cancer patients, screening of patients with Lynch syndrome and their family members, and assisting with proper management and intervention.
